Li Long
15Patents
5h-index
29Co-inventors
62Inventor score
Filing activity: Oct 31, 2007 → Apr 7, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8080246B2 | Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules | Chemistry; Metallurgy | 47 | Active |
| US8277810B2 | Antagonist anti-CD40 antibodies | Chemistry; Metallurgy | 27 | Active |
| US8637032B2 | Antagonist anti-CD40 monoclonal antibodies and methods for their use | Chemistry; Metallurgy | 23 | Active |
| US8183207B2 | Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules | Chemistry; Metallurgy | 22 | Active |
| US10011658B2 | Constructs targeting AFP peptide/MHC complexes and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US9926371B2 | M-CSF specific monoclonal antibody and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US8951972B2 | FGFR1 extracellular domain combination therapies for lung cancer | Chemistry; Metallurgy | 1 | Active |
| US9079956B2 | M-CSF specific monoclonal antibody and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US9522186B2 | M-CSF specific monoclonal antibody and uses therof | Chemistry; Metallurgy | 1 | Active |
| US10301388B2 | Antibody agents specific for human CD19 and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11981742B2 | Antibody agents specific for human CD19 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10016484B2 | Methods of treating lung cancer | Chemistry; Metallurgy | 0 | Active |
| US11709991B2 | Detecting truncation and overlap defects on webpage | Physics | 0 | Active |
| US11034759B2 | Humanized M-CSF specific monoclonal antibodies, kits, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10537611B2 | Methods of treating lung cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.